CDC5L, known to be involved in various cancers, including non-small cell lung cancer, hepatocellular cancer, and colorectal cancer 11-14, was observed in our study to be associated with larger tumor volume, advanced T and N stages, and advanced pathological grades in GC. Here, CDC5L is linked to gastric cancer.